Glucose & Insulin

Insulin & Glucagon Together Reduce Hypoglycemia Risk

Hypoglycemia is a major risk for people with diabetes on insulin-containing regimens. These risks are even greater in those taking beta-blockers, as symptoms of low blood sugar can be masked by the drug. However, administering insulin with glucagon may help to reduce the risk, researchers say. Read more

Good Glucose Control Helps Reduce Coronavirus Risks

People with diabetes are at greater risk for severe complications of COVID-19, but researchers say people with well-controlled blood glucose levels, defined as 70-72mg/dL.(3.9-10 mmol/L), have better COVID-19 treatment outcomes.  Read more

An Intestinal Film to Block Glucose Uptake

Researchers at Massachusetts Institute of Technology (MIT) have developed a new synthetic film that could help manage diabetes. The material would be consumed as a liquid; the film has the ability to self-assemble in the intestine to block the absorption of glucose, and subsequently dissolve. Read more

Insulin Challenges for Many Amid COVID-19 Pandemic

People with diabetes are at higher risk for complications of COVID-19, and good diabetes management is key for maximizing health and reducing risk. But for many with type 1, obtaining insulin is a challenge due to job and health insurance losses in the pandemic. Read more

Glucose Management Helps Reduce Cognitive Decline Risk

As people age, obesity and diabetes put them at higher risk for cognitive conditions like Alzheimer’s Disease. Type 2 diabetes damages the brain regions that govern memory, movement, and visual processing, but maintaining good glucose levels can help reduce the risk. Read more

CGM for Pregnant Women with Type 1

For pregnant women with type 1 diabetes, their maternal glucose levels play a large role in determining fetal growth. Continuous glucose monitoring (CGM) allows expecting mothers to assess the changes in their blood glucose levels. Read more

Oral Semaglutide Effective Paired with Insulin

Multiple studies have been conducted to evaluate the performance of oral semaglutide, which is the first oral medication in the glucagon-like peptide-1 (GLP-1) receptor agonist drug class. The PIONEER 8 trial found reductions in A1c and body weight when oral semaglutide is paired with various insulin regimens. Read more

A Micro Artificial Pancreas to Begin Trials

Betalin Therapeutics says that it will submit a request next month for human clinical trials in the UK for its tiny micro-pancreas that can “cure” diabetes for millions of people and eliminate the need for insulin injections. The device is designed for people with type 1 diabetes, and those with type 2 diabetes who require […]

“Metabolic Memory” of Poor Glucose Control Can Last a Lifetime

Researchers have found a strong association between early episodes of poor blood sugar control, epigenetic changes (which affect the activity of particular genes without altering their DNA sequences), and diabetic complications years later, even if patients subsequently had better glycemic control. Read more

Saliva Glucose Testing May Be Non-Invasive Alternative

Lab research suggests that saliva testing may one day offer a more cost-effective and painless alternative to finger sticks for measuring glucose levels and monitoring diabetes management. Read more

Is COVID-19 Quarantine Affecting Glucose Management?

Many countries have enacted lockdowns in order to combat the spread of coronavirus (COVID-19). These stay-at-home orders have disrupted daily routines for many diabetes patients, which has created concerns over the possible consequences of added stress, isolation, and elevated blood sugars on glucose management. Read more

Exercising and Managing Insulin with Type 1

Balancing blood glucose levels during (and after) exercise with type 1 diabetes is key if you want to be successful at being physically active as an insulin user, and want to prevent hypoglycemia or hyperglycemia during exercise. Diabetes exercise expert Dr. Sheri Colberg shares some tips for managing insulin, food, and exercise. Read more

Once-Weekly Insulin Shows Promise for Type 2

Currently there is no such thing available as a once-weekly insulin product. However, a new type of insulin, called insulin icodec, is showing promise in testing, and may one day offer people with type 2 a more convenient option for taking insulin. Read more

Glycemic Control in Young Americans with Diabetes Getting Worse

Blood glucose control among youth with diabetes has not improved since 2002 levels, and has actually gotten worse in some subgroups, according to data presented at the virtual American Diabetes Association (ADA) 2020 Scientific Sessions. This is despite increased availability of diabetes technology and new therapies in recent decades, and despite more aggressive recommended blood […]

New Insulin Hybrid Uses Sea Snails

An international team of researchers reported they have developed the world’s smallest, fully functional version of the insulin hormone. This version combines the potency of human insulin with the fast-acting potential of a venom insulin produced by predatory cone snails. Read more

New ADA Program Caps Insulin Co-pays for Medicare Recipients

The American Diabetes Association (ADA) joined the Centers for Medicare and Medicaid Services (CMS) in announcing the Part D Senior Savings Model, which will limit the cost of insulin for participating seniors to a maximum of $35 for a 30-day supply.  Read more

High Glucose Linked to Maternal Mortality

A recent study has found that elevated pre-pregnancy hemoglobin A1c, which measures average blood glucose concentration, is associated with higher risk of adverse pregnancy outcomes, even in women who have not been diagnosed with diabetes. Read more

People with Type 2 Produce Excess Glucagon

People who have type 2 diabetes do not only lack the right amount of insulin, they also produce excess glucagon, researchers say. Both these factors contribute to poor blood glucose control, researchers have said. Glucagon, which is produced by alpha cells in the pancreas, helps the body to regulate glucose and fats; both it and […]

Earlier Insulin Treatment for Type 2 Patients?

Irl B. Hirsch, MD, professor of medicine at the University of Washington in Seattle, argues that insulin treatment should begin earlier to improve outcomes for people with type 2 diabetes. While many people with type 2 have early success with standard treatment — including weight loss, diet changes, and various oral medications — the majority […]

Is Prediabetes Really Diabetes?

Researchers have found that people whose blood glucose readings are classified as prediabetes are already at increased risk for many complications of diabetes, including retinopathy, peripheral neuropathy, and diabetic nephropathy, and some experts suggest that treatment should begin far earlier to prevent these complications. Read more